RxDoctor Payments Data

Mary Klockmann

Nurse Practitioner · Brawley, CANPI 1003840174

Payments from drug & device makers

$6,344in general payments, 2019–2025

Across 231 payments — averaging $27.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Novo Nordisk$1K
  • Lilly USA, LLC$755
  • Amgen$443
  • Corcept Therapeutics$391
  • Phathom Pharmaceuticals, Inc.$316
  • plus $2K from 26 others

What the payments were for

  • Food & beverage$6,24498%
  • Education$1002%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,344 in reported general payments places this provider in the 95th percentile of 6,779 nurse practitioner providers in California.

See all nurse practitioner providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
RybelsusSemaglutide49$64,592
OzempicSemaglutide41$41,583
JardianceEmpagliflozin22$18,807
FarxigaDapagliflozin Propanediol17$13,857
Icosapent Ethyl33$9,866
VascepaIcosapent Ethyl13$8,662
Rosuvastatin Calcium62$1,927
Levothyroxine Sodium87$1,636
Ezetimibe16$1,466
Atorvastatin Calcium69$1,426
Omeprazole44$855
Azelastine Hcl35$805
Pioglitazone Hcl16$679
Amlodipine Besylate68$632
Lisinopril50$599

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus, Ozempic$1,422$106,17590 claims
Boehringer IngelheimJardiance$79$18,80722 claims
AstraZenecaFarxiga$1,435$13,85717 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,779 nurse practitioner providers in California.

Other nurse practitioner in Brawley

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →